Skin and Soft Tissue Infections
📧 Sign up to get email alerts when something new happens for Skin and Soft Tissue Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-08Clinical Trial Update: Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections [Phase 3]
A Phase 3 trial compared ceftaroline fosamil with vancomycin plus aztreonam in adults with complicated skin and soft tissue infections; resu…
-
FDA approval · 2010-06-07FDA Approved: CEFUROXIME AXETIL — Original Application (Golden State Medical Supply, Inc.)
FDA approved an original application for cefuroxime axetil from Golden State Medical Supply, Inc. for use as an oral antibiotic (ANDA).
-
CLINICAL_TRIALS trial_result · 2010-02-03Clinical Trial Update: Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections [Phase 2]
Phase 2 safety and efficacy study of a fluoroquinolone for complicated skin infections completed; results posted.
-
CLINICAL_TRIALS trial_result · 2010-01-11Clinical Trial Update: Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) [Phase 2]
Phase 2 trial evaluating telavancin versus standard therapy for complicated Gram-positive skin and soft tissue infections has completed and …
-
FDA approval · 2009-06-18FDA Approved: CEFTRIAXONE — Supplemental Application (Baxter Healthcare Company)
FDA approved a supplemental application for ceftriaxone sodium (ceftriaxone) from Baxter Healthcare Company, authorizing changes to the appr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-02-02FDA Approved: AMOXICILLIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for amoxicillin from Teva Pharmaceuticals USA, Inc., resulting in updated labeling and specification…
-
FDA approval · 2008-12-30FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Mylan Institutional LLC)
FDA approved the original application for vancomycin hydrochloride from Mylan Institutional LLC, marking the approval of a generic injectabl…
-
FDA approval · 2008-09-18FDA Approved: CLARITHROMYCIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Clarithromycin from Sandoz Inc, marking regulatory clearance for changes to this generic ant…
-
FDA approval · 2008-01-16FDA Approved: CEFPROZIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for cefprozil from Lupin Pharmaceuticals, Inc., resulting in updated labeling under the supplemental…
-
FDA approval · 2007-09-27FDA Approved: CEPHALEXIN — Supplemental Application (AVKARE)
FDA approved a supplemental application for Cephalexin submitted by AVKARE, indicating an approved modification to this product's label or a…
-
FDA approval · 2007-09-27FDA Approved: CEPHALEXIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cephalexin from Teva Pharmaceuticals USA, Inc., representing an approved modification to the exi…
-
FDA approval · 2007-08-20FDA Approved: CLARITHROMYCIN — Original Application (Chartwell RX, LLC.)
FDA approved a generic version of clarithromycin from Chartwell RX, LLC through an Original Abbreviated New Drug Application (ANDA).
-
FDA approval · 2007-07-25FDA Approved: CEPHALEXIN — Original Application (Chartwell RX, LLC)
FDA approved an Original Application for generic Cephalexin by Chartwell RX, LLC, adding a generic option for this antibiotic.
-
FDA label_change · 2007-06-05FDA Approved: BACTRIM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved a supplemental application for BACTRIM (sulfamethoxazole and trimethoprim) to modify the labeling.
-
FDA approval · 2007-04-26FDA Approved: ZYVOX — Supplemental Application (Hp Halden Pharma AS)
The FDA approved a supplemental application for Zyvox (linezolid) submitted by Hp Halden Pharma AS.
-
CLINICAL_TRIALS trial_result · 2007-01-30Clinical Trial Update: Trimethoprim-Sulfamethoxazole or Doxycycline for Skin and Soft Tissue Infections [NA]
The trial evaluating trimethoprim-sulfamethoxazole or doxycycline for skin and soft tissue infections has completed.